Here's why the EMvision share price surged 8% on Wednesday

Investors appear happy about an agreement EMvision has struck with tech company Keysight Technologies.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • EMvision shares are racing higher today following a company update
  • The company has entered into a strategic agreement with a long-term partner Keysight Technologies
  • In the last 12 months the EMvision share price has fallen more than 38%

The EMvision Medical Devices Ltd (ASX: EMV) share price has emerged from a trading halt on Wednesday morning, and shot 8% into the green.

Prior to their halt, EMVision shares closed at $1.94. Upon returning to trade, they have been sitting in the green amid the release of a company announcement. At the time of writing, EMvision shares are swapping hands at $2.05.

A guy wearing glasses tries to show off his muscles.

Image source: Getty Images

What did EMVision announce?

The company advised it has entered into an original equipment manufacturer (OEM) agreement with Keysight Technologies Inc (NYSE: KEYS).

According to the release, "Keysight is the world leader in radiofrequency (RF) test and measurement technology". Specifically, the company signed its agreement with Keysight's Australian subsidiary.

Under the agreement, EMvision will receive exclusive supply for 'fast sweep' features in the vector network analyser (VNA).

For reference, EMvision says the VNA is a custom solution developed in collaboration with Keysight.

"The VNA is a high performance, lower component count, miniaturised module responsible for accurate signal measurement," states the release.

"The custom VNA represents a strategic investment by Keysight into the electromagnetic imaging sector."

Regarding the announcement, EMvision CEO Dr Ron Weinberger says the collaboration "has been first class".

This Agreement recognises the roles that both parties have played in the development of the bespoke VNA over a period of 3 years. I would like to thank the Keysight team for their concerted work in developing a best-of-breed solution for EMvision and look forward to the commercial phase of our relationship.

Noteworthy is that Keysight is not a medical device manufacturer. However, it does possess "the strongest portfolio of Vector Network Analysers (VNA), which are core to the sensors that are being used inside EMvision's portable brain scanner," says the company.

The agreement builds on a relationship that spawned back in 2019. Then, the pair entered into a strategic collaboration to develop "custom healthcare-focused VNA solutions".

EMvision share price snapshot

In the last 12 months the EMvision share price has fallen more than 38%. Meanwhile, it is 23.5% in the red since trading resumed this year.

Following this announcement, shares have bounced from a low point and are tracking back towards monthly highs.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended EMvision Medical Devices Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A man looking at his laptop and thinking.
Technology Shares

Should I invest $2,500 into WiseTech shares?

There are clear risks here, but I think patient investors may still find a compelling long-term opportunity.

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Technology Shares

Has the WiseTech share price finally hit the bottom after crashing 50%?

Has this beaten-down ASX tech stock finally found its floor?

Read more »

A silhouette of a soldier flying a drone at sunset.
Technology Shares

How high does Macquarie think this ASX drone technology company will go?

Surging defence spending bodes well for this manufacturer.

Read more »

Man on a ladder drawing an increasing line on a chalk board, symbolising a rising share price.
Technology Shares

Why this ASX software stock is rocketing 13% today

Investors are buying after the company lifted its profit outlook.

Read more »

A young woman with glasses holds a pencil to her lips as she is surrounded by the reflection of data as though she is being photographed through a glass screen project with digital data.
Technology Shares

NEXTDC boosts funding with $2.3 billion senior debt facility upsize

NEXTDC has increased its available senior debt facilities to $8.7 billion to support ongoing expansion.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Technology Shares

Two ASX tech shares hinge on rebuilding trust and growth. Here's how they can turn around

Here is how both ASX tech shares can achieve a turnaround.

Read more »

A woman with her hands over her face splits her fingers over one eye so she can peep through them.
Technology Shares

How low could WiseTech shares go?

WiseTech shares are now down almost 70% over the past 12 months.

Read more »

Man on computer looking at graphs.
Technology Shares

Why the WiseTech share price is sinking 7% today

This fallen ASX tech favourite is sliding again today.

Read more »